Cambridge, MA, United States of America

Christophe Y Clement

This inventor holds 3 USPTO granted patents. Top assignee: Harvard College. Active years: 2000-2004.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Christophe Y Clement

Introduction

Christophe Y Clement is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of platelet activation proteins. With a total of 3 patents to his name, his work has implications for medical research and therapeutic applications.

Latest Patents

Clement's latest patents include a groundbreaking invention related to platelet activation proteins. One of his patents describes a substantially pure platelet activation polypeptide that includes a sequence at least 70% identical to SEQ ID NO:1, along with a DNA encoding such a polypeptide. This innovation has the potential to advance our understanding of platelet function and its role in various medical conditions.

Career Highlights

Clement is affiliated with Harvard College, where he conducts research and develops his inventions. His work at this prestigious institution has allowed him to collaborate with leading experts in the field, further enhancing the impact of his innovations.

Collaborations

One of his notable collaborators is Guy L Reed, with whom he has worked on various projects related to platelet activation and its implications in health and disease.

Conclusion

Christophe Y Clement's contributions to the field of biotechnology through his patents and research at Harvard College highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…